physostigmine has been researched along with deanol in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (90.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
Bralower, M; Tarsy, D | 1 |
Casey, DE | 1 |
Lakke, JP; Lindeboom, SF | 1 |
Casey, DE; Denney, D | 1 |
Chang, S; Davis, JM; Ericksen, SE; Smith, RC; Tamminga, CA | 1 |
Chang, S; Crayton, JW; Ericksen, SE; Klass, D; Smith, RC | 1 |
Jeste, DV; Wyatt, RJ | 1 |
Alphs, LD; Davis, JM | 1 |
3 review(s) available for physostigmine and deanol
Article | Year |
---|---|
Deanol in the management of involuntary movement disorders: a review.
Topics: Acetylcholine; Deanol; Dopamine; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Models, Neurological; Movement Disorders; Parkinson Disease; Physostigmine; Research Design; Time Factors | 1977 |
Therapeutic strategies against tardive dyskinesia. Two decades of experience.
Topics: Antipsychotic Agents; Choline; Clinical Trials as Topic; Deanol; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Parasympatholytics; Phosphatidylcholines; Physostigmine | 1982 |
Cholinergic treatments for tardive dyskinesia.
Topics: Acetylcholine; Antipsychotic Agents; Choline; Clinical Trials as Topic; Corpus Striatum; Deanol; Dopamine; Dyskinesia, Drug-Induced; Humans; Parasympathomimetics; Phosphatidylcholines; Physostigmine; Research Design; Substance Withdrawal Syndrome | 1983 |
6 trial(s) available for physostigmine and deanol
Article | Year |
---|---|
Deanol acetamidobenzoate treatment in choreiform movement disorders.
Topics: Benztropine; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Huntington Disease; Male; Middle Aged; Physostigmine | 1977 |
Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias.
Topics: Aged; Clinical Trials as Topic; Deanol; Double-Blind Method; Drug Evaluation; Dyskinesia, Drug-Induced; Ethanolamines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Physostigmine; Placebos | 1978 |
Pharmacological characterization of tardive dyskinesia.
Topics: Adult; Benztropine; Clinical Trials as Topic; Deanol; Dopamine; Droperidol; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Physostigmine; Placebos; Time Factors | 1977 |
Cholinergic influences in tardive dyskinesia.
Topics: Acetylcholine; Administration, Oral; Basal Ganglia; Choline; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Hypnotics and Sedatives; Injections, Intravenous; Methohexital; Motor Activity; Neostigmine; Physostigmine; Placebos; Receptors, Dopamine | 1977 |
Therapeutic strategies against tardive dyskinesia. Two decades of experience.
Topics: Antipsychotic Agents; Choline; Clinical Trials as Topic; Deanol; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Parasympatholytics; Phosphatidylcholines; Physostigmine | 1982 |
Cholinergic treatments for tardive dyskinesia.
Topics: Acetylcholine; Antipsychotic Agents; Choline; Clinical Trials as Topic; Corpus Striatum; Deanol; Dopamine; Dyskinesia, Drug-Induced; Humans; Parasympathomimetics; Phosphatidylcholines; Physostigmine; Research Design; Substance Withdrawal Syndrome | 1983 |
3 other study(ies) available for physostigmine and deanol
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
Electrophysiological (H-reflex) studies of patients with tardive dyskinesia.
Topics: Amphetamine; Apomorphine; Deanol; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrophysiology; H-Reflex; Humans; Motor Neurons; Muscles; Neurons, Afferent; Physostigmine; Receptors, Dopamine; Reflex, Monosynaptic; Schizophrenia | 1977 |